Clinical Trial

The Impact of a Dietary Fiber Enriched Diet on the Outcome of Patients with Liver Cirrhosis

Study acronym: ChainCirr
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated October 9, 2024 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
Summary
The goal of this dietary intervention is to study the impact of a dietary fiber enriched diet on the intestinal dysbiosis, systemic inflammation and cirrhosis-related complications in patients with liver cirrhosis. Therefore, our aim is to investigate the impact of a dietary fiber enriched diet on * frailty and sarcopenia * systemic inflammation * microbiome composition * quality of life and the composition of patients diet. Participants receive a dietary counselling and will be asked to increase their dietary fiber intake. As malnutrition is a common complication in cirrhosis and patients with advanced liver disease often show a disability to meet their daily food-requirements, the recommended intake of 30 gram dietary fibers per day is unlikely in this group of patients. Therefore, the fiber-enriched diet will be supplemented by the physiological short-chain-fatty-acid propionate, as a fiber-surrogate.
Trial Details
NCT Number NCT06634186
Lead Sponsor Hannover Medical School
Conditions Liver Cirrhosis
Enrollment 38 participants
Start Date 2023-01-23
Primary Completion 2024-12 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2024-10-09